Drug Profile


Alternative Names: UP 78842

Latest Information Update: 21 Nov 2007

Price : $50

At a glance

  • Originator UPSA
  • Class Anti-ischaemics; Antihypertensives; Benzoic acids
  • Mechanism of Action Beta-adrenergic receptor antagonists; Diuretics
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Hypertension; Ischaemic heart disorders

Most Recent Events

  • 23 Sep 1997 No-Development-Reported for Hypertension in United Kingdom (Unknown route)
  • 23 Sep 1997 No-Development-Reported for Hypertension in South Africa (Unknown route)
  • 23 Sep 1997 No-Development-Reported for Ischaemic heart disorders (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top